Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-01-27

Clinical Trial Update: Lippia Alba for Migraine Prophylaxis and Treatment [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Lippia Alba for migraine prevention and treatment has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lippia Alba

Snippet

Sponsor: Fabio Carmona | Conditions: Migraine Disorders | Phase 2 | Status: COMPLETED